Annual Meeting of the German Society for Biomaterials (DGBM)

Jahrestagung der Deutschen Gesellschaft für Biomaterialien
7–8 October 2021 • digital

Annual Meeting of the German Society for Biomaterials (DGBM)

Jahrestagung der Deutschen Gesellschaft für Biomaterialien
7–8 October 2021 • digital

Congress details

Print-File

Welcome note

Dear colleagues and friends,

it is an honor and a pleasure for me to invite you to the next annual conference of the German Society for Biomaterials in October 2021. Due to the actual pandemic we had already postponed the conference for one year. Actually, the situation is still not clear: many people are already vaccinated and hopefully most of us will have a vaccination until October but there are still numerous risks, mainly due to the effectiveness of the vaccinations against virus mutations.

Under these conditions we have decided to organize the meeting as a completely digital conference. This was not an easy decision for us, but fortunately, our congress organizers, Conventus, have gained a lot of experience with this format and therefor we are looking forward to an interesting virtual meeting with a lot of discussion on new developments and ideas.

The members of the scientific committee of this year’s conference are working in the state of Baden-Württemberg which is not only the European heart of the medical device industry with centers like Tuttlingen and Hechingen but has also achieved a dominant role in biotechnology with research centers and numerous startups as well as established companies around the Universities of Tübingen, Heidelberg and Freiburg. This is now even known around the world due to the impressive developments of Curevac for the Covid-vaccination. Thus, there is the opportunity to combine technical, material and pharmaceutical aspects of medical sciences and this combination is also a challenge for our Biomaterials Community. Functionalization is currently one of the major goals of improving biomaterials. This covers several areas: better "communication" of devices with the surrounding tissue, enabling and guiding regeneration and immunological processes, avoiding infections as well as many other aspects. We have therefore chosen these themes for the topics of this year's conference.

Finally our efforts and achievements should result in new and better treatments and products for patients. We will therefore place particular emphasis on translational aspects and encourage physicians and medical scientists as well as companies to report on medical needs and successful translations into the clinic. For this purpose, we have planned a live video-chat in an operation theater with surgeons in Tübingen, where actual medical needs will be demonstrated on human body preparations.

Biomedical sciences have always been very international and we commonly work together with colleagues all over the world. So, we keep this new tradition of our society to invite all of you to meet members of the German Biomaterials Society and discuss with us latest developments. Therefore the conference language will be English.

We are looking forward meeting you all virtually this October

Best regards
Michael Doser

Conference Chair